Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-06-06
1999-04-06
Jarvis, William R.A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
058919236
ABSTRACT:
This invention relates to the use of R(+)-N-propargyl-1-aminoindan and pharmaceutically acceptable salts thereof for the treatment of dementia.
REFERENCES:
patent: 3201470 (1965-08-01), Huebner
patent: 3253037 (1966-05-01), Huebner
patent: 3513244 (1970-05-01), Gittos et al.
patent: 4826875 (1989-05-01), Chiesi
patent: 5196583 (1993-03-01), Yamada et al.
patent: 5387612 (1995-02-01), Youdim et al.
patent: 5453446 (1995-09-01), Youdim et al.
patent: 5457133 (1995-10-01), Youdim et al.
patent: 5519061 (1996-05-01), Youdim et al.
patent: 5532415 (1996-07-01), Youdim et al.
Tariot et al, Biological Abstracts, vol. 84, Abstract No. 18676, 1987.
Finberg et al. Chemical Abstracts, vol. 103, Abstract No. 81618, 1985.
Finberg, Tenne & Youdin, Chemical Abstracts, Abstract No. 202499, 1981, vol. 94.
Finberg and Youdim, British J. Pharmac. (Jun. 1985) 85(2):541-546.
Kabins and Gershon, Dementia (1990) 1:323-348.
The Merck Index (Tenth ed. 1983) pp. 149, 248-249.
The Parkinson Study Group, New England J. Med. (1989) 321(20):1364-1371.
The Parkinson Study Group, New England J. Med. (Jan. 21, 1993) 328(3):176-183.
Riederer and Youdim, J. Neurochem. (1986) 46(5):1359-1365.
Tekes, et al., Pol. J. Pharmacol. Pharm. (1988) 40:653-658.
Youdim, et al., in Handbook of Experimental Pharmacology vol. 90/I (1988) Chapter 3, Trendelenburg and Weiner, eds.
Finberg John P.M.
Levy Ruth
Yellin Haim
Youdim Moussa B.H.
Jarvis William R.A.
Technion Research and Development Foundation Ltd.
Teva Pharmaceutical Industries Ltd.
White John P.
LandOfFree
R-enantiomer of N-propargyl-1-aminoindan for the treatment of de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R-enantiomer of N-propargyl-1-aminoindan for the treatment of de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-enantiomer of N-propargyl-1-aminoindan for the treatment of de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1371840